在Oligodendrogliomas中CDKN2A/B变化的频率和预后影响:系统性审查和元分析
Satoshi Nakasu1, Shoichi Deguchi2,3, Yoko Nakasu4,3
1Division of Neurosurgery, Omi Medical Center.
Neurologia medico-chirurgica
|October 23, 2024
概括
循环素依赖性激酶2A/B (CDKN2A/B-HomoD) 的同胞性缺失与分子定义的寡质瘤的生存率较差有关. 这种基因变异在3级瘤中更频繁,其检测方法影响报告的频率.
科学领域:
- 神经瘤学神经瘤学
- 分子病理学分子病理学
- 遗传学 是一个遗传学.
背景情况:
- 异酸脱酶 (IDH) 突变天体细胞瘤具有对循环素依赖激酶2A/B (CDKN2A/B-HomoD) 的同胞性缺失,属于世卫组织4级.
- 对于CDKN2A/B-HomoD在寡头质瘤中的临床意义尚不清楚.
研究的目的:
- 系统地审查和对分子定义的寡质瘤 (mOlig) 的文献进行元分析.
- 为了确定mOlig.中的CDKN2A/B基因变异的频率和预后意义.
主要方法:
- 系统的文献综述和元分析.
- 包括关于分子定义的寡质瘤 (mOlig) 的研究.
- 分析总体存活率和CDKN2A/B变化的频率,考虑世卫组织等级和检测方法.
主要成果:
- 患有CDKN2A/B-HomoD的患者的整体存活率明显降低 (综合危险比2.44).
- 在3级的mOlig中CDKN2A/B-HomoD的发生率比2级 (0.31%) 高 (9.4%).
- 检测方法,特别是光现场杂交 (FISH),影响了CDKN2A/B-HomoD.的报告频率.
结论:
- CDKN2A/B-HomoD是分子定义的小腺瘤中显著的负预后标志物.
- 根据瘤等级和检测方法,CDKN2A/B-HomoD的频率有所不同.
- 需要对其他CDKN2A/B变异进行进一步的研究,例如突变,半删除和促进物甲基化.
相关概念视频
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...


